Wellington Partners

Wellington Partners

  • Home
  • Team
  • Approach
  • Portfolio
  • News
  • Contact

News

Confo Therapeutics expands board with appointment of Rob Scott as Independent Director

Details
Published: 10 June 2020
  • portfolio-news

Confo Therapeutics today announced the appointment of Rob Scott as an Independent Director. Dr. Scott’s career spans 30 years of drug discovery and development leadership in the global pharmaceutical and biotechnology industries, including his last position as Chief Medical Officer, Head of Development at AbbVie.

© Wellington Partners, 2021.
  • WP Technology Funds
  • Contact
  • Imprint
  • Privacy